Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Verteporfin therapy in Age-related Macular Degeneration (VAM): An open-label multicenter photodynamic therapy study of 4,435 patients
Neil M. Bressler
Research output
:
Contribution to journal
›
Article
›
peer-review
31
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Verteporfin therapy in Age-related Macular Degeneration (VAM): An open-label multicenter photodynamic therapy study of 4,435 patients'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Age Related Macular Degeneration
100%
Verteporfin
100%
Photodynamic Therapy
100%
Subretinal Neovascularization
28%
Adverse Event
21%
Photosensitivity
21%
Fluorescein
14%
Backache
7%
Neuroscience
Age-Related Macular Degeneration
100%
Verteporfin
100%
Choroidal Neovascularization
28%
Fluorescein
14%
Angiography
7%
Keyphrases
Verteporfin
100%
Closeout
16%
Direct Sunlight
8%
Safety Information
8%
Uncorrected Distance Visual Acuity
8%
Acute Severe
8%
Visudyne
8%
Eyewear
8%
Nursing and Health Professions
Photosensitivity
21%
Corrected Distance Visual Acuity
7%
Fluorescein
7%
Fluorescence Angiography
7%
Medicine and Dentistry
Corrected Distance Visual Acuity
7%